Centre Unveils 30% Trade Margin Cap For 137 Cancer Drugs

Hold onto your lab coats, folks! The Centre just unveiled a dazzling 30% trade margin cap on 137 cancer drugs, including heavyweights like Nivolumab and Olaparib. This game-changing move kicks in on November 9, 2026, promising savings of up to 70%! Get ready to save big while keeping those pharmacies on their toes.